Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
|
February 6, 2007
Neurobiology of dynamic psychotherapy: an integration possible?
Emanuela Mundo
CNS Spectrums
|
November 1, 2006
Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series
Bernardo Dell'Osso, Emanuela Mundo, A Carlo Altamura
Journal of Affective Disorders
|
March 21, 2006
Clinical variables related to antidepressant-induced mania in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Michela Russo, et al.
The International Journal of Neuropsychopharmacology
|
October 8, 2004
Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study
A Carlo Altamura, Claudio Montresor, Daniele Salvadori, et al.
Neuropsychiatric Disease and Treatment
|
May 5, 2009
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, et al.
Human Psychopharmacology
|
October 31, 2002
Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine
Emanuela Mundo, Frédéric Rouillon, M. Luisa Figuera, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 23, 2008
Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series
Bernardo Dell'osso, Emanuela Mundo, Donatella Marazziti, et al.
Neuropsychiatric Disease and Treatment
|
June 24, 2008
Duration of untreated illness in panic disorder: a poor outcome risk factor?
A Carlo Altamura, Annalisa Santini, Daniele Salvadori, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 6, 2008
May duration of untreated illness influence the long-term course of major depressive disorder?
A Carlo Altamura, Bernardo Dell'osso, Serena Vismara, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 6, 2007
The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders
Silvio R Bareggi, Emanuela Mundo, Bernardo Dell'Osso, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry
|
February 6, 2007
Neurobiology of dynamic psychotherapy: an integration possible?
Emanuela Mundo
CNS Spectrums
|
November 1, 2006
Quetiapine augmentation of selective serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a six-month follow-up case series
Bernardo Dell'Osso, Emanuela Mundo, A Carlo Altamura
Journal of Affective Disorders
|
March 21, 2006
Clinical variables related to antidepressant-induced mania in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Michela Russo, et al.
The International Journal of Neuropsychopharmacology
|
October 8, 2004
Does comorbid subthreshold anxiety affect clinical presentation and treatment response in depression? A preliminary 12-month naturalistic study
A Carlo Altamura, Claudio Montresor, Daniele Salvadori, et al.
Neuropsychiatric Disease and Treatment
|
May 5, 2009
The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder
Emanuela Mundo, Elisabetta Cattaneo, Silvia Zanoni, et al.
Human Psychopharmacology
|
October 31, 2002
Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine
Emanuela Mundo, Frédéric Rouillon, M. Luisa Figuera, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 23, 2008
Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series
Bernardo Dell'osso, Emanuela Mundo, Donatella Marazziti, et al.
Neuropsychiatric Disease and Treatment
|
June 24, 2008
Duration of untreated illness in panic disorder: a poor outcome risk factor?
A Carlo Altamura, Annalisa Santini, Daniele Salvadori, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
February 6, 2008
May duration of untreated illness influence the long-term course of major depressive disorder?
A Carlo Altamura, Bernardo Dell'osso, Serena Vismara, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
October 6, 2007
The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders
Silvio R Bareggi, Emanuela Mundo, Bernardo Dell'Osso, et al.
Page
of 4